2017-2018 Session

Change Session

S.175 (Act 133)

An act relating to the wholesale importation of prescription drugs into Vermont

Sponsor(s)

Last Recorded Action

Senate 5/12/2018 - Signed by Governor on May 16, 2018

Bill/Resolution Text

As Introduced
As Passed By the Senate
Official | Unofficial
House Proposal of Amendment
Official | Unofficial
As Passed by Both House and Senate
Official | Unofficial
As Enacted | Act Summary

NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.

Detailed Status

	Body	Date	Journal	Calendar	Location	Full Status

Roll Call History

	Body	Date	Journal	Location	Full Status

Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.

Summary List Full List

Committee Meetings

Meeting Date	Committee

Meeting Full List

Print Report

Thursday, January 18, 2018

Committee(s):: Senate Committee on Health and Welfare
9:00 AM: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Sen. Tim Ashe, Sponsor
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
Peter Welch, U.S. Congressman, Vermont
John Tracy, Field Representative, Office of Senator Patrick Leahy
Trish Riley, Executive Director, National Academy of State Health Policy

Friday, January 26, 2018

Committee(s):: Senate Committee on Health and Welfare
9:15 AM: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Kevin Mullin, Chair, Green Mountain Care Board
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Nate Awrich, Manager of Pharmacy Operations, University of Vermont Health Network
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Rebecca Heintz, General Counsel, Blue Cross/Blue Shield of Vermont
Mark Hage, Member Benefits Director, Vermont-NEA
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
Theo Kennedy, Lobbyist, Vermont Retail Druggists
Jeff Hochberg, President, Vermont Retail Druggists

Tuesday, January 30, 2018

Committee(s):

Senate Committee on Health and Welfare

11:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America PhRMA
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health

11:15 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion and Possible Mark-up

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Susan Barrett, Executive Director, Green Mountain Care Board

Friday, February 2, 2018

Committee(s):: Senate Committee on Health and Welfare
10:30 AM: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Susan Barrett, Executive Director, Green Mountain Care Board
Jamie Feehan, Lobbyist, Property & Casualty Insurance Association and State Farm
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association

Tuesday, February 6, 2018

Committee(s):

Senate Committee on Health and Welfare

`

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion, Possible Mark-up and Vote

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health

Wednesday, February 7, 2018

Committee(s):

Senate Committee on Health and Welfare

9:45 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion and Possible Vote

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services

Friday, February 9, 2018

Committee(s):

Senate Committee on Finance

2:30 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Walk thru of bill by drafter

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines

Tuesday, February 13, 2018

Committee(s):

Senate Committee on Finance

2:30 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Possible Vote

Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Friday, February 23, 2018

Committee(s):: Senate Committee on Appropriations
1:00 PM: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Sen. Claire Ayer
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Thursday, March 15, 2018

Committee(s):

House Committee on Health Care

10:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Walk-through with Legislative Counsel

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

11:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Continue walk-through of the bill.

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health

Thursday, March 22, 2018

Committee(s):

House Committee on Health Care

9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Overview; Sec. 1 of the bill--importation of prescription drugs; fiscal note.

Sen. Tim Ashe, Sponsor
John Tracy, Field Representative, Office of Senator Patrick Leahy
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Peter Welch, U.S. Congressman, Vermont
Trish Riley, Executive Director, National Academy of State Health Policy
Jane Horvath, National Academy of State Health Policy
Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
Bernie Sanders, U.S. Senator
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Friday, March 23, 2018

Committee(s):

House Committee on Health Care

8:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Background; prescription drug transparency; reports from the Attorney General's Office

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jill Abrams, Assistant Attorney General, Attorney General's Office

Wednesday, March 28, 2018

Committee(s):

House Committee on Health Care

9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Sec. 1, Importation of drugs, continued; Section 2, Bulk purchasing

Cory Gustafson, Commissioner, Department of Vermont Health Access (DVHA)
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Theo Kennedy, Lobbyist, Vermont Retail Druggists
Jeff Hochberg, President, Vermont Retail Druggists
Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines

10:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Section 6: "Gag rule"

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jeff Hochberg, President, Vermont Retail Druggists
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Jamie Feehan, Lobbyist, CVS/Caremark
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare

Thursday, March 29, 2018

Committee(s):

House Committee on Health Care

9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Testimony on Sections 3 and 4 --Health Insurance Plan Reporting; Impact of Prescription Drug Costs on Health Insurance Premiums

Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Susan Barrett, Executive Director, Green Mountain Care Board
Kevin Mullin, Chair, Green Mountain Care Board

Wednesday, April 4, 2018

Committee(s):

House Committee on Health Care

9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Thursday, April 5, 2018

Committee(s):

House Committee on Health Care

11:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Review draft and Committee discussion

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Wednesday, April 11, 2018

Committee(s):

House Committee on Health Care

9:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

10:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion; follow-up from work group on current prescription drug pricing law.

Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Jill Abrams, Assistant Attorney General, Attorney General's Office
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Bridget Morris, Lobbyist, Association for Accessible Medicines

Thursday, April 12, 2018

Committee(s):: House Committee on Ways and Means
9:30 AM: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Thursday, April 12, 2018

Committee(s):

House Committee on Health Care

3:00 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Focus on drug importation & bulk purchasing

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Friday, April 13, 2018

Committee(s):

House Committee on Health Care

11:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion (S.262 discussion postponed to next week)

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

2:15 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Final markup and possible vote. S.175 only.
Time changed to 2:15 PM or after discussion on S.92

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Wednesday, April 18, 2018

Committee(s):: House Committee on Ways and Means
9:00 AM: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
3:15 PM: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Al Gobeille, Secretary, Agency of Human Services
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Thursday, April 19, 2018

Committee(s):: House Committee on Ways and Means
After the Floor: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Friday, April 20, 2018

Committee(s):

House Committee on Ways and Means

9:15 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

potential vote

Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Friday, April 20, 2018

Committee(s):

House Committee on Health Care

--After the Floor

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Bill As Recommended by House Ways and Means Committee.
https://legislature.vermont.gov/assets/Documents/2018/WorkGroups/House%20Health%20Care/Bills/S.175/S.175~House%20Ways%20and%20Means%20Committee~S.175,%20As%20Recommended%20by%20House%20Ways%20and%20Means%20Committee~4-20-2018.pdf

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Rep. George W. Till
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Tuesday, April 24, 2018

Committee(s):

House Committee on Health Care

1:00 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion: Amendment from House Ways and Means

Rep. Mary S. Hooper, Sponsor of amendment
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Wednesday, April 25, 2018

Committee(s):: House Committee on Appropriations
11:30 AM: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Rep. William J. Lippert, Chair, House Committee on Health Care

Thursday, April 26, 2018

Committee(s):

Senate Committee on Health and Welfare

8:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee Discussion

Thursday, May 3, 2018

Committee(s):: Senate Committee on Health and Welfare
9:00 AM: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Monday, May 7, 2018

Committee(s):: Senate Committee on Health and Welfare
9:00 AM: S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Sen. Michael Sirotkin, Reporter, Senate Committee on Finance

Committee Documents

Witnesses Who Testified

Print Report

House Committee on Appropriations

Rep. William J. Lippert, Chair, House Committee on Health Care

House Committee on Health Care

Jill Abrams, Assistant Attorney General, Attorney General's Office
Sen. Tim Ashe, Sponsor
Susan Barrett, Executive Director, Green Mountain Care Board
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Jamie Feehan, Lobbyist, CVS/Caremark
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Cory Gustafson, Commissioner, Department of Vermont Health Access (DVHA)
Jeff Hochberg, President, Vermont Retail Druggists
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Rep. Mary S. Hooper, Sponsor of amendment
Jane Horvath, National Academy of State Health Policy
Theo Kennedy, Lobbyist, Vermont Retail Druggists
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Bridget Morris, Lobbyist, Association for Accessible Medicines
Kevin Mullin, Chair, Green Mountain Care Board
Trish Riley, Executive Director, National Academy of State Health Policy
Bernie Sanders, U.S. Senator
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Rep. George W. Till
John Tracy, Field Representative, Office of Senator Patrick Leahy
Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines
Peter Welch, U.S. Congressman, Vermont

House Committee on Ways and Means

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Al Gobeille, Secretary, Agency of Human Services
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Senate Committee on Appropriations

Sen. Claire Ayer
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Senate Committee on Finance

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines

Senate Committee on Health and Welfare

Sen. Tim Ashe, Sponsor
Nate Awrich, Manager of Pharmacy Operations, University of Vermont Health Network
Susan Barrett, Executive Director, Green Mountain Care Board
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Jamie Feehan, Lobbyist, Property & Casualty Insurance Association and State Farm
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Mark Hage, Member Benefits Director, Vermont-NEA
Rebecca Heintz, General Counsel, Blue Cross/Blue Shield of Vermont
Jeff Hochberg, President, Vermont Retail Druggists
Theo Kennedy, Lobbyist, Vermont Retail Druggists
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America PhRMA
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
Kevin Mullin, Chair, Green Mountain Care Board
Trish Riley, Executive Director, National Academy of State Health Policy
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Sen. Michael Sirotkin, Reporter, Senate Committee on Finance
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
John Tracy, Field Representative, Office of Senator Patrick Leahy
Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
Peter Welch, U.S. Congressman, Vermont

Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.

Fiscal Information

Print Report

Fiscal Notes and Related Documents

No committee of conference members found for S.175 in the 2017-2018 Legislative Session.

Summary List Full List

Committee of Conference Meetings

Meeting Date	Committee

Committee of Conference Meeting Full List

Print Report

No committee of conference meeting history found for S.175 in the 2017-2018 Legislative Session.

No committee of conference report found for S.175 in the 2017-2018 Legislative Session.

Act

Signed into law 5/16/2018
As Enacted (ACT 133)
Act Summary

Statutes Affected

Statute
18 V.S.A. § 4651. Wholesale importation program for prescription drugs; design
18 V.S.A. § 4652. Monitoring for anticompetitive behavior
18 V.S.A. § 4653. Federal compliance
18 V.S.A. § 4654. Program financing
18 V.S.A. § 4655. Implementation provisions
18 V.S.A. § 4656. Annual reporting

Staff & Other Information

Print Report

Staff: Jennifer Carbee, Legislative Counsel

Search

Bills

Resolutions

Acts

Research

House Committees

Senate Committees

Committee Types

All Committee Meetings

Research

Statutes

Constitution

Acts

Search

Rules

The House of Representatives

Officers

Calendars & Journals

Rules

Search

Related Information

The Senate

Officers

Calendars & Journals

Rules

Search

Related Information

Reports

Research

PRA Exemptions

History

The State House

History

Civic Education

Galleries

Events

House

Senate

Staff Offices

Contact

Career Opportunities

2017-2018 Session

An act relating to the wholesale importation of prescription drugs into Vermont

Detailed Status

2017-2018 Legislative Session

An act relating to the wholesale importation of prescription drugs into Vermont

Roll Call History

2017-2018 Legislative Session

An act relating to the wholesale importation of prescription drugs into Vermont

Committee Meetings

2017-2018 Legislative Session

An act relating to the wholesale importation of prescription drugs into Vermont

Meeting Full List

2017-2018 Legislative Session

Thursday, January 18, 2018

Friday, January 26, 2018

Tuesday, January 30, 2018

Friday, February 2, 2018

Tuesday, February 6, 2018

Wednesday, February 7, 2018

Friday, February 9, 2018

Tuesday, February 13, 2018

Friday, February 23, 2018

Thursday, March 15, 2018

Thursday, March 22, 2018

Friday, March 23, 2018

Wednesday, March 28, 2018

Thursday, March 29, 2018

Wednesday, April 4, 2018

Thursday, April 5, 2018

Wednesday, April 11, 2018

Thursday, April 12, 2018

Thursday, April 12, 2018

Friday, April 13, 2018

Wednesday, April 18, 2018

Thursday, April 19, 2018

Friday, April 20, 2018

Friday, April 20, 2018

Tuesday, April 24, 2018

Wednesday, April 25, 2018